Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Classement en actions #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Prix de l'action
$0.0202
Dernière synchronisation: 2024-11-19
Capitalisation boursière
$44.67K
Changement (1 jour)
-0.49%
Changement (1 an)
0.00%
Pays
IL
Échange Notable Labs, Ltd. (NTBL)

Catégorie

Historique du prix de l'action pour Notable Labs, Ltd. (NTBL)
Prix de clôture le plus élevé : $0.07 le 2024-11-01

Prix de clôture le plus bas : $220.88 le 2014-10-01
Historique du prix de l'action de Notable Labs, Ltd. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -97.63%
2023 -35.28%
2022 -94.02%
2021 21.62%
2020 45.36%
2019 14.25%
2018 -84.70%
2017 40.20%
2016 -5.03%
2015 -14.31%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$525.78 32.80%
US
$874.09 35.18%
NL
$746.78 9.21%
CH
$1.08K -6.68%
KR
$261.19 17.24%
BE